We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hyaluronic Acid Agents Could Prevent Adhesions After Gynecologic Surgery

By HospiMedica staff writers
Posted on 18 Jun 2007
Adhesion formation after fertility-preserving gynecologic surgery may be decreased with the use of hyaluronic acid-based fluid agents, according to a new study.

Researchers at the University of Sheffield (United Kingdom; www.shef.ac.uk) conducted a meta-analysis of available studies from the Cochrane menstrual disorders and subfertility group specialized register of controlled trials, The Cochrane central register of controlled trials, MEDLINE, and EMBASE and identified four randomized controlled trials of hyaluronic acid fluid agents compared with no treatment or placebo in women undergoing fertility-preserving gynecologic surgery.

An association was observed between the use of hyaluronic acid agents and a decrease in the prevalence of adhesions at second-look laparoscopy. More...
Patients treated with hyaluronic acid also had a decreased chance of deterioration of preexisting adhesions. However, the researchers concluded that the severity of adhesions should not be used as a surrogate marker for future fertility potential, and therefore, future studies should include live birth rate as a primary outcome measure and have adequate follow-up periods. The study was published in the May 2007 issue of Fertility and Sterility.

"Intraperitoneal adhesions are an important cause of postoperative intestinal obstruction, abdominal discomfort, and infertility,” said lead author Dr. Mostafa Metwally. "Despite careful attention to minimize tissue trauma and ensure hemostasis, pelvic surgery is associated with both de novo adhesion formation and reformation.”

Hyaluronic acid (also called hyaluronan or hyaluronate) is a glycosaminoglycan found in lubricating proteoglycans of the synovial fluid, vitreous humors, cartilage, blood vessels, skin, and the umbilical cord. It is one of the chief components of the extracellular matrix, and contributes significantly to cell proliferation and migration.


Related Links:
University of Sheffield

New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Syringe Pump
SP50 Series
New
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.